BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 37953829)

  • 1. From Genotype to Phenotype: How Enhancers Control Gene Expression and Cell Identity in Hematopoiesis.
    Mulet-Lazaro R; Delwel R
    Hemasphere; 2023 Nov; 7(11):e969. PubMed ID: 37953829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis.
    Huang J; Liu X; Li D; Shao Z; Cao H; Zhang Y; Trompouki E; Bowman TV; Zon LI; Yuan GC; Orkin SH; Xu J
    Dev Cell; 2016 Jan; 36(1):9-23. PubMed ID: 26766440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis.
    Aranda-Orgilles B; Saldaña-Meyer R; Wang E; Trompouki E; Fassl A; Lau S; Mullenders J; Rocha PP; Raviram R; Guillamot M; Sánchez-Díaz M; Wang K; Kayembe C; Zhang N; Amoasii L; Choudhuri A; Skok JA; Schober M; Reinberg D; Sicinski P; Schrewe H; Tsirigos A; Zon LI; Aifantis I
    Cell Stem Cell; 2016 Dec; 19(6):784-799. PubMed ID: 27570068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of Hhex in hematopoiesis and hematopoietic stem cell ontogeny.
    Migueles RP; Shaw L; Rodrigues NP; May G; Henseleit K; Anderson KG; Goker H; Jones CM; de Bruijn MF; Brickman JM; Enver T
    Dev Biol; 2017 Apr; 424(2):236-245. PubMed ID: 28189604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the RUNX1 Enhancer in Normal Hematopoiesis and Leukemogenesis.
    Liau WS; Ngoc PC; Sanda T
    Adv Exp Med Biol; 2017; 962():139-147. PubMed ID: 28299656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulatory network controlling the ontogeny of hematopoietic stem cells.
    Gao P; Chen C; Howell ED; Li Y; Tober J; Uzun Y; He B; Gao L; Zhu Q; Siekmann AF; Speck NA; Tan K
    Genes Dev; 2020 Jul; 34(13-14):950-964. PubMed ID: 32499402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancers and MYC interplay in hematopoiesis.
    Benetatos L; Benetatou A; Vartholomatos G
    J Mol Med (Berl); 2020 Apr; 98(4):471-481. PubMed ID: 32144465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and Analysis of Janelia FlyLight Project Enhancer-Gal4 Strains Identifies Multiple Gene Enhancers Active During Hematopoiesis in Normal and Wasp-Challenged
    Tokusumi T; Tokusumi Y; Brahier MS; Lam V; Stoller-Conrad JR; Kroeger PT; Schulz RA
    G3 (Bethesda); 2017 Feb; 7(2):437-448. PubMed ID: 27913635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular understanding of super-enhancer dysregulation in cancer.
    Yoshino S; Suzuki HI
    Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of haematopoietic stem cells.
    Wilkinson AC; Göttgens B
    Adv Exp Med Biol; 2013; 786():187-212. PubMed ID: 23696358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies.
    Warr MR; Pietras EM; Passegué E
    Wiley Interdiscip Rev Syst Biol Med; 2011; 3(6):681-701. PubMed ID: 21412991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of RBPMS as a mammalian smooth muscle master splicing regulator via proximity of its gene with super-enhancers.
    Nakagaki-Silva EE; Gooding C; Llorian M; Jacob AG; Richards F; Buckroyd A; Sinha S; Smith CWJ
    Elife; 2019 Jul; 8():. PubMed ID: 31283468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood disease-causing and -suppressing transcriptional enhancers: general principles and
    Bresnick EH; Johnson KD
    Blood Adv; 2019 Jul; 3(13):2045-2056. PubMed ID: 31289032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETS transcription factors in hematopoietic stem cell development.
    Ciau-Uitz A; Wang L; Patient R; Liu F
    Blood Cells Mol Dis; 2013 Dec; 51(4):248-55. PubMed ID: 23927967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative Transcription Factor Induction Mediates Hemogenic Reprogramming.
    Gomes AM; Kurochkin I; Chang B; Daniel M; Law K; Satija N; Lachmann A; Wang Z; Ferreira L; Ma'ayan A; Chen BK; Papatsenko D; Lemischka IR; Moore KA; Pereira CF
    Cell Rep; 2018 Dec; 25(10):2821-2835.e7. PubMed ID: 30517869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
    Sanda T; Leong WZ
    Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcriptional coactivator Cbp regulates self-renewal and differentiation in adult hematopoietic stem cells.
    Chan WI; Hannah RL; Dawson MA; Pridans C; Foster D; Joshi A; Göttgens B; Van Deursen JM; Huntly BJ
    Mol Cell Biol; 2011 Dec; 31(24):5046-60. PubMed ID: 22006020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise Review: Epigenetic Regulation of Hematopoiesis: Biological Insights and Therapeutic Applications.
    Antoniani C; Romano O; Miccio A
    Stem Cells Transl Med; 2017 Dec; 6(12):2106-2114. PubMed ID: 29080249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of sequence determinants of enhancer function using natural genetic variation.
    Yang MG; Ling E; Cowley CJ; Greenberg ME; Vierbuchen T
    Elife; 2022 Aug; 11():. PubMed ID: 36043696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of hematopoietic and leukemic stem cells by the immune system.
    Riether C; Schürch CM; Ochsenbein AF
    Cell Death Differ; 2015 Feb; 22(2):187-98. PubMed ID: 24992931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.